COS1, a two-component histidine kinase that is involved in hyphal development in the opportunistic pathogen Candida albicans by Alex, Lisa A. et al.
Proc. Natl. Acad. Sci. USA
Vol. 95, pp. 7069–7073, June 1998
Microbiology
COS1, a two-component histidine kinase that is involved in
hyphal development in the opportunistic pathogen
Candida albicans
LISA A. ALEX*, CHRISTOPHER KORCH†, CLAUDE P. SELITRENNIKOFF†, AND MELVIN I. SIMON*‡
*Division of Biology 147–75, California Institute of Technology, Pasadena, CA 91125; and †Department of Cellular and Structural Biology, University of Colorado
Health Sciences Center, 4200 E. Ninth Avenue, Denver, CO 80262
Contributed by Melvin I. Simon, April 3, 1998
ABSTRACT Two-component histidine kinases recently
have been found in eukaryotic organisms including fungi,
slime molds, and plants. We describe the identification of a
gene, COS1, from the opportunistic pathogen Candida albicans
by using a PCR-based screening strategy. The sequence of
COS1 indicates that it encodes a homolog of the histidine
kinase Nik-1 from the filamentous fungus Neurospora crassa.
COS1 is also identical to a gene called CaNIK1 identified in C.
albicans by low stringency hybridization using CaSLN1 as a
probe [Nagahashi, S., Mio, T., Yamada-Okabe, T., Arisawa,
M., Bussey, H. & Yamada-Okabe, H. (1998) Microbiol. 44,
425–432]. We assess the function of COS1yCaNIK1 by con-
structing a diploid deletion mutant. Mutants lacking both
copies of COS1 appear normal when grown as yeast cells;
however, they exhibit defective hyphal formation when placed
on solid agar media, either in response to nutrient deprivation
or serum. In constrast to the Dnik-1 mutant, the Dcos1yDcos1
mutant does not demonstrate deleterious effects when grown
in media of high osmolarity; however both Dnik-1 and Dcos1y
Dcos1 mutants show defective hyphal formation. Thus, as
predicted for Nik-1, Cos1p may be involved in some aspect of
hyphal morphogenesis and may play a role in virulence
properties of the organism.
One of the most common fungal pathogens in humans is
Candida albicans. Although C. albicans is normally present in
the gastrointestinal tract and does not cause disease, weaken-
ing of the host immune system through a variety of factors,
such as administration of chemotherapeutic agents for cancer
treatment or the presence of AIDS, often leads to colonization
of tissues and resulting disease (1, 2). Systemic fungal infec-
tions are difficult to treat because most antifungal compounds
exhibit unpleasant side effects and toxicities. Increasing resis-
tance to antifungal compounds by common pathogens, as well
as the increasing number of individuals who find themselves
with compromised immunological function, warrants an in-
creased understanding of the basic biology of fungi to identify
potential antifungal targets. A number of factors have been
implicated as being associated with the virulence properties of
C. albicans, such as adherence to host cells and the ability to
undergo the transition from yeast to hyphal growth known as
dimorphism (3, 4). Recent studies from a number of labora-
tories have taken advantage of the fact that Saccharomyces
cerevisiae can be induced to grow filamentously (pseudohyphal
growth) (5) and that genes involved in the yeast-to-hyphal
transition in C. albicans often can complement defects in genes
in the S. cerevisiae pathway. This approach has led to the
identification of a MAPK pathway involving the Candida
genes CST20, HST7, and CPH1, which are homologs of the
Saccharomyces STE20, STE7, and STE12 genes, respectively,
that play a dual role in mating as well as in pseudohyphal
growth (6–9). Deletion of the Candida genes results in organ-
isms that are impaired in the ability to make hyphae under
selected conditions, although not in response to serum (6–9).
This result suggests that there is more than one pathway
controlling hyphal growth. Previous work has demonstrated
that, in S. cerevisiae, an additional mutation in the PHD1 gene
is required to completely inhibit the filamentous transition of
ste12 strains (10). EFG1, a PHD1 homolog, has been found in
C. albicans, and its reduced expression causes loss of true
hyhae formation (11). When double cph1ycph1 efg1yefg1 Can-
dida mutants were made, they were unable to form hyphae
under any condition tested and were avirulent in a mouse
model (10). Additionally, a homolog of Saccharomyces cerevi-
siae Cla4p (a Ste20-like kinase) has been found in C. albicans
(CaCla4p), and its deletion causes a complete abrogation of
hyphal formation under all conditions (12). These mutants also
demonstrate a loss of virulence in mice. This loss may be
caused by the involvement of CaCla4p in polarized cell growth
as demonstrated in S. cerevisiae. Recently, a gene encoding a
protein with integrin-like properties was found in C. albicans.
This protein, Int1p, is found on the cell surface and has been
shown to affect the virulence properties of C. albicans. Dele-
tion mutants of INT1 have reduced adherence to epithelial
cells, and the deletion causes loss of hyphal formation (13).
The above studies taken together demonstrate the importance
of the transition from yeast-like to hyphal growth in Candida
virulence.
The involvement of homologous genes in controlling fila-
mentous growth suggests that morphogenetic events involved
in hyphal formation in various fungi may be conserved. We
have shown previously that, in the filamentous fungus Neuro-
spora crassa, a two-component histidine kinase, Nik-1, is
involved in proper hyphal development and protection against
increased environmental osmostress (14, 15). Unlike S. cer-
evisiae and C. albicans, N. crassa exhibits hyphal growth until
it undergoes asexual spore formation, when it subsequently
divides by budding (16). Deletion of nik-11 causes multiple
morphological defects such as misshapen hyphae that lyse and
reduced conidiation. Under increased osmotic pressure, these
defects become severe, resulting in loss of hyphal and spore
formation capabilities. These characteristics are found for a
number of osmotic mutants of N. crassa; os-1, os-2, os-4, os-5,
and cut. (17). Osmotic mutants all demonstrate defective
hyphal formation, reduced conidiation, and sensitivity to
increased osmostress (17, 18). Osmotic mutants also are known
to be insensitive to a number of dicarboximide fungicides (19)
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and have altered cell wall compositions (20, 21). Recently, the
gene for one of the osmotic loci, os-1, was cloned by functional
complementation of os-1 mutants and was shown to be iden-
tical to nik-11 (15). The PCR-based screening method that led
to the original identification of nik-11 has been used subse-
quently to identify a homolog in C. albicans. In this report, we
describe the isolation and characterization of COS1, whose
predicted protein sequence shows it to be a member of the
hybrid family of histidine kinases and a homolog of Nik-1
(Os-1) from N. crassa. As in N. crassa, Cos1p plays a role in
hyphal development under certain growth conditions in C.
albicans that will be discussed.
MATERIALS AND METHODS
Molecular Biological Manipulations. All common molecu-
lar biological manipulations were performed by using standard
methods or as described by the manufacturer. DNA sequenc-
ing was done by using dye terminator and dye primer chem-
istries on an automated sequencer (Applied Biosystems mod-
els 373 and 377) at the California Institute of Technology DNA
Sequencing Facility. All DNA sequence data manipulation was
performed with SEQUENCHER (version 2.1, Gene Codes, Ann
Arbor, MI). Homology searches and alignments were done by
using programs of the GCG package.
Strains and Culture Conditions. The C. albicans strains used
in this work are listed in Table 1 (22, 23). C. albicans strains
were grown routinely in yeast extractypeptoneydextrose with
uridine added to a final concentration of 50 mgyml when
necessary. Selection of URA3 transformants was done on agar
plates of SD [0.67% (wtyvol) yeast nitrogen base without
amino acids and 2% (wtyvol) glucose, final concentration].
Hyphal formation was monitored at 37°C by several methods:
incubation of cells in liquid yeast extractypeptoneydextrose
with 10% (volyvol) bovine serum (Sigma), incubation in liquid
Spider medium (6), incubation on solid Spider plates, and
incubation on agar plates [Difco, 1.2% (wtyvol)] containing
10% (volyvol) bovine serum.
Identification of the COS1 Histidine Kinase Domain in C.
albicans. The PCR primers H1A [CA(TyC)GAI(AyTy
C)TI(CyA)GIACICC] and N2A [GC(AyG)TTIC(TyC)IA-
CIA(GyA)(GyA)TT] (14) were used to amplify genomic DNA
from wild-type C. albicans (ATCC 36801). C. albicans genomic
DNA was prepared as described (24). PCRs contained 2.5 mM
each primer, 1.5 mg genomic DNA, and 2.5 mM each dATP,
dCTP, dGTP, and dTTP in 10 mM TriszHCl (pH 8.3), 50 mM
KCl, 0.001% (wtyvol) Gelatin, 0.5 units of Amplitaq (Perkin–
ElmeryCetus) in a total volume of 100 ml. In a Perkin–Elmer
thermocycler, all reaction components except the nucleotides
and polymerase were incubated at 95°C (10 min) and then
cooled to 4°C. Polymerase and nucleotides were added, and
the reaction was cycled 30 times with the sequence at 94°C (1
min), 40°C (1 min), and 72°C (1 min) followed by extension at
72°C (10 min). PCR products were separated and purified by
electrophoresis through a 1.5% (wtyvol) agarose gel. The
purified products were ligated into a T-vector (Promega) and
then sequenced.
Isolation of C. albicans COS1. The PCR product generated
from amplification of genomic C.albicans DNA was used to
screen a size-selected C. albicans genomic library. The library
was generated either by cloning size-selected HindIIIyBamHI
fragments of C. albicans ATCC 366 genomic DNA into pUC19
digested with the same restriction enzymes or by cloning 7- to
10-kb HindIII fragments of the same DNA into HindIII
digested pUC19. Two clones were obtained that provided the
templates for sequencing the COS1 gene. One is pCHK1,
which has a 9.0-kb HindIII insert, and the other is pCA3.8,
which has a 3.8-kb HindIIIyBamHI overlapping insert of
genomic DNA of pCHK1. The sequence of COS1 was obtained
by primer walking on both strands of pCHK2 and pCA3.8.
Construction of COS1 Deletion Mutant. Both alleles of
COS1 were deleted by using the ‘‘URA blaster’’ technique
(23). A 1.3-kb XhoIyNcoI fragment was removed from pCA3.8,
and the NcoI site was blunted by treatment with Klenow
fragment. To this was ligated a 3.6-kb SalIyBglII fragment
from pBC19 in which the BglII site was blunted with Klenow.
pBC19 is pUC19 where the BamHI site was converted to BglII
and subsequently used to clone a BglIIySalI fragment from
pCUB6 containing the hisG-URA3-hisG cassette (B. Cormack,
Stanford University, unpublished results). The resulting plas-
mid is pKOCOS-1. Spheroplasts of C. albicans strain CAI4
(ura-) were transformed with pKOCOS-1 linearized with
HindIII and ura1 transformants selected on SD plates con-
taining 1 M sorbitol. Genomic DNA was isolated from several
transformants and digested with BglII. DNA fragments were
resolved by electrophoresis through an 0.8% (wtyvol) agarose
gel and transferred to a nylon membrane. Blots were probed
with a PCR fragment, which corresponds to nucleotides 3528–
3996 of the genomic sequence, that was generated with the
primers CA13 [TGGTACAGGTTTAGGGTTGTC] and
CA15 [AACATGGCGTATTTGCATAGG]. Recombinants
containing one wild-type allele and one disrupted allele
(LAC13) were identified by the presence of the desired
restriction fragments. One hisG repeat and the URA3 marker
were removed by selection of LAC13 cells on media containing
5-fluoroorotic acid as described (25) except that uridine was
substituted for uracil. The loss of hisG-URA3 was followed by
Southern blotting with both the CA13yCA15 PCR product and
the URA3 gene as probes. This yielded clones LAC14 and
LAC15 (Dcos1::hisGyCOS1). These cells then were subjected
to a second round of transformation and analysis as described
for replacement of the first allele to give LAC16 and LAC18
Table 1. C. albicans strains
Strain Genotype Reference
366 wild-type isolate ATCC
36801 wild-type isolate ATCC
SC5314 wild-type isolate (22)
CAI4 Dura3::imm434yDura3::imm434 (23)
LAC13 Dura3::imm434yDura3::imm434yDcos1::hisG-URA3-hisGyCOS1 This work
LAC14 Dura3::imm434yDura3::imm434yDcos1::hisGyCOS1 This work
LAC15 Dura3::imm434yDura3::imm434yDcos1::hisGyCOS1 This work
LAC16 Dura3::imm434yDura3::imm434yDcos1::hisGyDcos1::hisG-URA3-hisG This work
LAC18 Dura3::imm434yDura3::imm434yDcos1::hisGyDcos1::hisG-URA3-hisG This work
LAC20 Dura3::imm434yDura3::imm434yDcos1::hisGyDcos1::hisG This work
LAC21 Dura3::imm434yDura3::imm434yDcos1::hisGyDcos1::hisG This work
LAC22 Dura3::imm434yDura3::imm434yDcos1::hisGyDcos1::hisG (2 m COS1) This work
LAC23 Dura3::imm434yDura3::imm434yDcos1::hisGyDcos1::hisG (2 m COS1) This work
LAC26 Dura3::imm434yDura3::imm434yDcos1::hisGyCOS1::URA3 This work
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(Dcos1::hisGyDcos1::hisG-URA3-hisG) and finally LAC20 and
LAC21 (Dcos1:hisGyDcos1::hisG).
Complementation of COS1 Deletion Mutant. To make the
template for homologous reintegration of the COS1 gene, the
9.0-kb HindIII fragment was removed from pCHK1 with
HindIII and cloned into the HindIII site of pBluescript SK1 to
give pBSCOS-1. A 1.3-kb fragment containing URA3 (gener-
ated from PCR amplification of pBC19 with U3BF [TG-
GATCCAGTACTAATAGGAATTGATTTGG] and U3BR
[TGGATCCTCTAGAAGGACCACCTTTGATTG], cloned
into a T-vector, and digested with BamHI, with the ends made
blunt by treatment with Klenow fragment) was ligated into the
EheI site downstream from COS1 in pBSCOS-1 to yield
pBSCOS-1yURA3. The relevant insert was isolated after
HindIII digestion and used to transform LAC20. Cells were
selected on SD containing 1 M sorbitol. Genomic DNA was
isolated from selected clones, digested with BglII, and blotted
to nylon. The PCR product CA13y15 was used to probe for the
reappearance of the desired band and yielded strains LAC26.
Alternatively, the Dcos1yDcos1 mutant LAC20 or LAC21 was
transformed with pYPBCOS-11, which is COS1 cloned into a
2-m-based plasmid. The plasmid pYPBCOS-11 was made by
digesting pYPB-ADHpt (8) with NotI and SalI to remove the
ADH promoter and ligating to this a NotIySalI fragment from
plasmid pT(CA32y33) containing COS1. PCR amplification
(Taqplus, Stratagene) of pCHK1 with the primers CA32
[ATGCGGCCGCGGAGTTATGAAAGTTGTGGGC] and
CA33 [ATGGTCGACAGTTCCTACACAACAATTTGGC]
yielded a fragment spanning nucleotides 1060–4865 of the
genomic sequence with an engineered NotI site at the 59 end
of the clone and a SalI site at the 39 end, which was cloned into
a T-vector (Promega) to give pT(CA32y33). The resulting
ura1 transformants (LAC22, LAC23) were selected on SD
plates containing 1 M sorbitol.
RESULTS
Sequence of COS1 from C. albicans. PCR screening of C.
albicans genomic DNA with degenerate primers that encode
the sequence of the H and N boxes of two-component histidine
kinases were used to clone a genomic DNA fragment that,
upon sequencing, demonstrated homology to other histidine
kinase family members (14). The fragment encoded a peptide
that was most similar to the sequence of the Nik-1yOs-1 kinase
from N. crassa (83% identity, data not shown). This PCR
fragment was used as a probe to screen a genomic C. albicans
library and led to the identifcation of a 9-kb HindIII and 3.8-kb
HindIIIyBamHI DNA fragment, which, upon subcloning, were
sequenced.
Translation of the COS1 gene from this fragment predicts a
polypeptide of 1,081 amino acids (mw 118, 983) that, when
aligned with other histidine kinases, demonstrated that, in fact,
we had cloned a homolog of Nik-1(Os-1) (70% similarity
overall); we call the gene ‘‘COS1’’ (Fig. 1) The sequence of the
ORF predicted from COS1 is shown aligned with Nik-1 from
N. crassa and the sequence of a translated DNA fragment that
we obtained by PCR in Aspergillus nidulans (L.A.A., unpub-
lished results) (Fig. 1). The sequence of Cos1p predicted from
the gene indicates that this protein is a member of the hybrid
family of histidine kinases, those that contain both a histidine
kinase domain and a response regulator domain (26). Mem-
bers of this class include the majority of histidine kinases
described in eukaryotic organisms including fungi, yeasts,
slime molds, and plants (reviewed in ref. 27). The overall
domain organization is conserved between the Nik-1 and
Cos1p, including the large N-terminal domain that contains
tandem repeats of 90 amino acids, which is predicted to form
a coiled-coil structure (14); however, Cos1p is missing one of
the six repeats found in Nik-1. Of interest, coiled-coil regions
have been implicated in the control of histidine kinase activity
as in the case of the regulation of CheA, the kinase that
controls bacterial chemotaxis (28). The major differences
between Cos1p and Nik-1 occur at the very amino- and
carboxy-terminal ends of the proteins. The N. crassa protein
contains a longer amino-terminal domain (Fig. 1). Like Nik-1,
Cos1p does not seem to contain regions that are likely to span
the lipid bilayer, and hence this protein may be soluble. We
note that there are two CTG codons that correspond to amino
acids 463 and 899 of Cos-1p, which are translated as SER in C.
albicans (29).
The POLIII gene is translated in the opposite direction to
COS1, and its 5-prime end is just upstream of the COS1 gene
(corresponding to nucleotide 960). Thus, the initiator ATGs of
POLIII and COS1 are only 434 bp apart but are translated in
opposite directions. There is a pyrimidine stretch (nucleotides
1,088–1,119) upstream from the predicted Cos-1p product as
well as potential CAAT boxes (nucleotides 1,131–1,134 and
FIG. 1. Predicted amino acid sequence of Cos1p aligned with
Nik-1(Os-1) of N. crassa and the homolog, AnNik-1, encoded by a
PCR product identified from Aspergillus nidulans (L.A.A., unpub-
lished results). Boxed residues are identical.
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1,379–1,382) and a potential TATA box (nucleotides 1,382–
1,385), which suggests that this region is the promoter for
COS1. Unlike nik-11, COS1 does not contain any introns.
Following the stop codon (nucleotides 4,702–4,704), there are
several AATAA sequences that may serve as Poly(A) addition
signals (nucleotides 4,768–4,775, 4,813–4,821, 5,016–5,023,
and 5,088–5,070). The genomic sequence of COS1 has been
deposited in GenBank with the accession number U69886.
Cos1p Is Involved in Hyphal Development in C. albicans. To
ascertain a possible role for Cos1p in C. albicans, we con-
structed a diploid deleted for both copies of the gene (Fig. 2).
The mutant and wild-type strains appeared similar when
grown in a variety of liquid media at 30°C (data not shown).
Upon deletion of only one copy (Dcos1yCOS1), we noticed
that the heterozygotes could not make hyphae as well as wild
type when grown at 37°C on solid agar plates, either under
conditions of nutrient deprivation (Fig. 3) or in response to
serum (Fig. 4). This phenotype was more exaggerated in the
Dcos1yDcos1 mutants. Thus, like N. crassa Nik-1, C. albicans
Cos1p is involved in hyphal development. One major differ-
ence is that the Dcos1 strains, when grown as yeasts, did not
exhibit the osmosensitivity that N.crassa Dnik-1 strains dem-
onstrate (data not shown). Increased osmolyte concentration
inhibits hyphal development in the wild type such that differ-
ences between the wild type and mutant were difficult to
assess. However, the effect on solid surfaces may be an
osmotic-like effect because it could be that reduced water
activity is the parameter actually being sensed. We were able
to partially complement the defect in hyphal formation by the
introduction of a wild-type copy of COS1 into Dcos1yDcos1
strains either by homologously recombining it back into the
genome or by expression from a 2 m-containing plasmid (Figs.
3 and 4).
FIG. 2. Disruption of the COS1 gene from C. albicans. (A)
Schematic showing the replacement strategy. Restriction sites are H
(HindIII), Bg (BglII), X (XhoI), N (NcoI), and E (EcoRI). (B)
Southern blot of genomic DNA to detect replacement of COS1
with hisG-URA3-hisG. After digestion of genomic DNA with BglII,
the replacement event was detected by probing with a PCR product
generated from CA13 and CA15 primers. Lanes: 1, CA I4 (wild-
type parent); 2, LAC13 (Dcos1::hisG-URA3-hisGyCOS1); 3, LAC15
(Dcos1::hisGyCOS1); 4, LAC18 (Dcos1::hisGyDcos1::hisG-URA3-
hisG); 5, CA I4 (wild type); 6, LAC13 (Dcos1::hisG-URA3-hisGy
COS1); 7, LAC14 (Dcos1::hisGyCOS1); 8, LAC17 (Dcos1::hisGy
Dcos1::hisG-URA3-hisG); 9, LAC16 (Dcos1::hisGyDcos1::hisG-URA3-
hisG).
FIG. 3. Morphology of C. albicans Dcos1yDcos1 colonies grown on
solid agar Spider media. Cells were grown at 37°C on solid Spider
plates for 5 days (a-d) or 4 days (e-g). (a and e) SC5314 (wild- type
COS1yCOS1); (b and f ) LAC13 (Dcos1yCOS1); (c) LAC16 (Dcos1y
Dcos1); (d) LAC26 (Dcos1yDcos1 strain in which COS1::URA3 has
been recombined back at the cos1 locus, Dcos1yCOS1::URA3); (g)
LAC18 (Dcos1yDcos1); (h) LAC23 (Dcos1yDcos1 with COS1 ex-
pressed from a 2-m plasmid).
FIG. 4. Morphology of C. albicans Dcos1/Dcos1 colonies grown at
37°C for 3 days on agar plates containing 10% (vol/vol) fetal bovine
serum. (a) SC5314 (wild-type COS1/COS1). (b) LAC13 (Dcos1/
COS1). (c) LAC16 (Dcos1/Dcos1). (d) LAC 22 (Dcos1/Dcos1 with
COS1 on 2-m plasmid). (e) LAC 18 (Dcos1/Dcos1). ( f) LAC 23
(Dcos1/Dcos1 with COS1 on 2-m plasmid).
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DISCUSSION
This work describes Cos1p, a eukaryotic two-component his-
tidine kinase from C. albicans that is a homolog of Nik-1 from
the filamentous fungus N. crassa. The same PCR-based strat-
egy used to clone nik-11 also allowed identification of COS1.
From previous work, Nik-1 was implicated in hyphal morpho-
genesis because deletion mutants exhibited multiple morpho-
logical defects including reduced conidiation and aberrant
hyphal structure with lysis. These defects were more dramatic
when cells were exposed to growth conditions of high osmo-
larity such that they could no longer form spores or make
hyphae (14). Staining with Calcofluor white showed that, when
Dnik-1 mutants were grown in high salt, they displayed defec-
tive cell wall structure (L.A.A., unpublished results). Thus, the
osmosensitivity observed is likely caused by altered cell wall
structure. When grown as yeasts on solid or liquid media,
Dcos1yDcos1 mutants did not exhibit osmosensitivity and
appeared like wild type (data not shown). However, when the
Dcos1yDcos1 mutants were placed on solid agar surfaces either
on Spider medium (Fig. 3) or with 10% serum (Fig. 4), they
showed a loss of hyphal formation compared with wild type.
This phenotype is similar to C. albicans mutants in HST7,
CST20, and CPH1, which are homologs of S. cerevisiae STE7,
STE20, and STE12, respectively (6–9). The S. cerevisiae genes
are involved in the MAPK pathway controlling pseudohyphal
formation in response to nitrogen starvation and may have
similar functions in C. albicans (30). hst7, ste20, and cph1
mutants only showed defects in hyphal formation when placed
on solid Spider medium but responded normally on solid
media with serum (6–9). Because it is known that, in S.
cerevisiae, the histidine kinase Sln1p is coupled to the HOG1-
MAPK pathway (31), deletion of the histidine kinase possibly
could be rescued by overproduction of some downstream
component. We were unable to rescue the cos1ycos1 mutant by
overexpressing HST7 (a MEKK), suggesting COS1 may lie in
a different pathway or interact with components downstream
of HST7 (L.A.A., unpublished results).
Investigators have reported the cloning of the S. cerevisiae
SLN1 homolog from C. albicans CaSLN1 (32). A diploid
knockout of CaSLN1 exhibited the osmosensitive phenotype
seen for the S. cerevisiae mutant. The sequence of a second
gene called CaNIK1 recently has been reported after its
identification by using low stringency hybridization with
CaSLN1 and is identical to COS1 (32). The phenotype of
Casln1yCasln1 mutants could not be rescued by overexpres-
sion of CaNIK1yCOS1 (32). This is consistent with our view
that Cos1p probably is involved in the regulation of some
aspect of cell wall maintenance during hyphal formation. Thus,
mutations in this gene would give rise to defective hyphal
formation and would have no effect on the yeast form. Because
the yeast-to-hyphal transition is important for C. albicans
virulence and Cos1p has a role in hyphal development, this
protein may be a potential antifungal target, a possiblity
currently under investigation.
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